Abbott’s first dual-analyte sensor comes as competitors are working to develop their own versions of the technology.

The recall is Insulet’s second this year related to tears in the device tubing. So far, 24 serious adverse events have been ...

Olympus said Tuesday it has agreed to buy Israel-based BioProtect for $270 million to expand its product portfolio in ...

Johnson & Johnson’s Abiomed has recommended updated use instructions for all of its Automated Impella Controllers in response ...

The device called Mint, which would work with the company’s adaptive insulin dosing algorithm, is expected to debut in the ...

The diabetes tech firm has identified two lots of G7 sensors that have been stolen, sold and used by customers.

The smart ring maker’s filing follows a recent $900 million fundraise and comes amid plans to develop more health features ...

Some updates to Intuitive’s surgical robot aim to improve communication between remote and on-site physicians to expand ...

The deal gives Boston Scientific a 34% equity stake in MiRus and an option to acquire its TAVR platform by making additional ...

Medtronic said Wednesday it has agreed to buy SPR Therapeutics, a company making a device that uses peripheral nerve ...

With the study results, Boston Scientific plans a regulatory submission for the intravascular lithotripsy treatment for ...

The Labcorp agreement continues the expansion of Aura, which gives healthcare providers access to tests from companies ...